Financials data is unavailable for this security.
View more
Year on year Fresenius Medical Care AG 's net income fell -25.90% from 673.41m to 499.00m despite relatively flat revenues.
| Gross margin | 25.14% |
|---|---|
| Net profit margin | 4.57% |
| Operating margin | 8.11% |
| Return on assets | 2.58% |
|---|---|
| Return on equity | 4.77% |
| Return on investment | 3.32% |
More ▼
Cash flow in EURView more
In 2023, Fresenius Medical Care AG increased its cash reserves by 12.05%, or 153.44m. The company earned 2.63bn from its operations for a Cash Flow Margin of 13.51%. In addition the company used 544.23m on investing activities and also paid 1.86bn in financing cash flows.
| Cash flow per share | 4.59 |
|---|---|
| Price/Cash flow per share | 4.76 |
| Book value per share | 24.31 |
|---|---|
| Tangible book value per share | -3.41 |
More ▼
Balance sheet in EURView more
| Current ratio | 1.37 |
|---|---|
| Quick ratio | 1.02 |
| Total debt/total equity | 0.8224 |
|---|---|
| Total debt/total capital | 0.431 |
More ▼
Growth rates in EUR
Year on year, growth in earnings per share excluding extraordinary items dropped -25.94%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
| Div yield(5 year avg) | -- |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 52.96% |
| EPS growth(5 years) | -23.40 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 46.46 |
More ▼
